Lupin Partners With SteinCares To Supply Biosimilar in LATAM
ECONOMY & POLICY

Lupin Partners With SteinCares To Supply Biosimilar in LATAM

Global pharmaceutical major Lupin Limited has entered into a licence and supply agreement with SteinCares, a leading Latin American speciality healthcare firm, for the commercialisation of Lupin’s biosimilar ranibizumab across Latin America, excluding Mexico and Argentina.

As per the agreement, SteinCares will manage all regulatory submissions, registrations, and commercial activities, while Lupin will be responsible for manufacturing the biosimilar.

Ranibizumab is a recombinant humanised monoclonal antibody fragment (IgG1) that targets and inhibits vascular endothelial growth factor A (VEGF-A). It is used to treat several retinal conditions including Neovascular (Wet) Age-Related Macular Degeneration (AMD), Macular Oedema following Retinal Vein Occlusion (RVO), Diabetic Macular Oedema (DME), Diabetic Retinopathy (DR), and Myopic Choroidal Neovascularisation (mCNV).

Dr Cyrus Karkaria, President of Biotechnology at Lupin, said, “This partnership underscores our commitment to making advanced retinal therapies accessible in Latin America and improving patients’ quality of life.”

Sebastián Katz, Chief Strategy Officer at SteinCares, added, “Our collaboration with Lupin bolsters our leadership in the biosimilar space and helps bring affordable, high-quality treatments to healthcare systems across the region.”

This partnership aims to enhance the reach of cost-effective, advanced ophthalmic treatments across Latin America, aligning with both companies’ missions to deliver impactful healthcare solutions.

Global pharmaceutical major Lupin Limited has entered into a licence and supply agreement with SteinCares, a leading Latin American speciality healthcare firm, for the commercialisation of Lupin’s biosimilar ranibizumab across Latin America, excluding Mexico and Argentina.As per the agreement, SteinCares will manage all regulatory submissions, registrations, and commercial activities, while Lupin will be responsible for manufacturing the biosimilar.Ranibizumab is a recombinant humanised monoclonal antibody fragment (IgG1) that targets and inhibits vascular endothelial growth factor A (VEGF-A). It is used to treat several retinal conditions including Neovascular (Wet) Age-Related Macular Degeneration (AMD), Macular Oedema following Retinal Vein Occlusion (RVO), Diabetic Macular Oedema (DME), Diabetic Retinopathy (DR), and Myopic Choroidal Neovascularisation (mCNV).Dr Cyrus Karkaria, President of Biotechnology at Lupin, said, “This partnership underscores our commitment to making advanced retinal therapies accessible in Latin America and improving patients’ quality of life.”Sebastián Katz, Chief Strategy Officer at SteinCares, added, “Our collaboration with Lupin bolsters our leadership in the biosimilar space and helps bring affordable, high-quality treatments to healthcare systems across the region.”This partnership aims to enhance the reach of cost-effective, advanced ophthalmic treatments across Latin America, aligning with both companies’ missions to deliver impactful healthcare solutions.

Next Story
Infrastructure Transport

PM to Inaugurate Indore Metro Phase 1 and Datia Satna Airports on May 31

Prime Minister Narendra Modi is scheduled to inaugurate the first phase of the Indore Metro Rail project, along with the Datia and Satna airports, via video conferencing during his visit to Bhopal on May 31, according to a senior Madhya Pradesh cabinet official.During his day-long visit to Bhopal, the Prime Minister will also participate in a conference organized to commemorate the 300th birth anniversary of Devi Ahilyabai Holkar, the historic queen of the Malwa kingdom, now part of Madhya Pradesh, as stated by the Parliamentary Affairs Minister and Cabinet spokesperson Kailash Vijayvargiya.It..

Next Story
Infrastructure Transport

Kochi Metro Holds Talks with BPCL to Restore Greenery on Medians

Kochi Metro Rail (KMRL), facing increasing criticism for not maintaining the green spaces along the medians in the metro corridor, has initiated discussions with Bharat Petroleum Corporation (BPCL) and the Ernakulam District Horticulture Society to revive the project.Sources reveal that KMRL is also making fresh efforts to find sponsors to care for and maintain the gardens located between the metro pillars. Previously, several sponsors had withdrawn, which led to the neglect of these green areas.There are 989 medians along the 28-km Kochi Metro stretch. Of these, 465 are under the National Hig..

Next Story
Infrastructure Transport

Rajasthan CM Approves DPR for Jaipur Metro Phase-2 Expansion

Rajasthan Chief Minister Bhajanlal Sharma approved the detailed project report (DPR) of Jaipur Metro Phase-2 and forwarded it to the Central Government.The construction work for the project is set to begin once the Union Ministry of Housing and Urban Affairs grants approval to the DPR.Phase 2 of Jaipur Metro had been announced in the state budget for 2025-26.The project, covering a 42.80-km stretch from Todi Mode to Prahladpura, will be implemented by the Rajasthan Metro Rail Corporation—a newly formed 50:50 joint venture between the state and Central governments. The corporation will be res..

Advertisement

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement

Advertisement

Advertisement

Advertisement

Talk to us?